Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	105170
Country	China

Received	2025-01-14 01:59
Peer-Review Started	2025-01-14 01:59
To Make the First Decision
Return for Revision	2025-03-05 01:13
Revised	2025-03-11 04:41
Second Decision	2025-04-18 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-04-18 06:59
Articles in Press	2025-04-18 06:59
Publication Fee Transferred	2025-03-13 07:47
Edit the Manuscript by Language Editor	2025-04-23 17:10
Typeset the Manuscript	2025-05-30 03:16
Publish the Manuscript Online	2025-06-13 13:39

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Retrospective Study
Article Title	Efficacy and safety of donafenib plus transarterial chemoembolization and immunotherapy for hepatocellular carcinoma
Manuscript Source	Unsolicited Manuscript
All Author List	Zhi-Hao Yang, Si-Nan Liu, Fu-Ying Chu, Cheng Yang and Xiang Chen
ORCID	Author(s) ORCID Number Xiang Chen http://orcid.org/0000-0002-2024-6994
Funding Agency and Grant Number
Corresponding Author	Xiang Chen, PhD, Department of Laboratory Medicine, Nantong First People’s Hospital and The Second Affiliated Hospital of Nantong University, Medical School of Nantong University, No. 666 Shengli Road, Nantong 226001, Jiangsu Province, China. ntchenx0520@163.com
Key Words	Hepatocellular carcinoma; Donafenib; Transarterial chemoembolization; Immunotherapy; Therapy
Core Tip	Transarterial chemoembolization combined with donafenib and immune checkpoint inhibitors has been clinically applied in patients with unresectable hepatocellular carcinoma. This study assesses the safety and efficacy of the aforementioned treatment strategy to better promote its adoption in clinical practice.
Publish Date	2025-06-13 13:39
Citation	<p>Yang ZH, Liu SN, Chu FY, Yang C, Chen X. Efficacy and safety of donafenib plus transarterial chemoembolization and immunotherapy for hepatocellular carcinoma. <i>World J Gastrointest Oncol</i> 2025; 17(6): 105170</p>
URL	https://www.wjgnet.com/1948-5204/full/v17/i6/105170.htm
DOI	https://dx.doi.org/10.4251/wjgo.v17.i6.105170

Full Article (PDF)	WJGO-17-105170-with-cover.pdf
Manuscript File	105170_Auto_Edited_074737.docx
Answering Reviewers	105170-answering-reviewers.pdf
Audio Core Tip	105170-audio.mp3
Biostatistics Review Certificate	105170-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form	105170-conflict-of-interest-statement.pdf
Copyright License Agreement	105170-copyright-assignment.pdf
Signed Informed Consent Form(s) or Document(s)	105170-informed-consent-statement.pdf
Institutional Review Board Approval Form or Document	105170-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate	105170-non-native-speakers.pdf
Peer-review Report	105170-peer-reviews.pdf
Scientific Misconduct Check	105170-scientific-misconduct-check.png
Scientific Editor Work List	105170-scientific-editor-work-list.pdf
CrossCheck Report	105170-crosscheck-report.pdf